Endpoints News 2025년 12월 8일 #ASH25: Will a biotech’s pivot away from obesity let it compete with Novartis in leukemia?
Endpoints News 2025년 11월 25일 Novartis was the sole bidder in $12B deal to buy Avidity #Avidity Biosciences #buy Avidity
Endpoints News 2025년 11월 24일 #ASH25: Kelonia’s first in vivo CAR-T data; Lilly, J&J and Novartis spell out Phase 3 wins #American Society #wins Late-breaking